Newer alternatives for resistant hypertension: Beyond 2022 paradigms

Given the increased incidence of resistant hypertension and no novel agents to manage hypertension for more than 15 years, there has been an increase in the development of newer agents with unique mechanisms that will hopefully aid in getting this subset of patients under control. More recent classe...

Full description

Bibliographic Details
Main Authors: Luke J. Laffin, Alexandros Briasoulis, George L. Bakris
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:Hellenic Journal of Cardiology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1109966623000222